Phase 2 study for people with Melanoma

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor Melanoma Institute Australia
Registry number NCT06767306
Started 6 March 2025 Today 16 October 2026 Estimated completion 1 April 2033

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Westmead Hospital Westmead NSW Recruiting
Melanoma Institute Australia Wollstonecraft NSW Recruiting
Princess Alexandra Hospital Woolloongabba QLD Recruiting
The Alfred Hospital Melbourne VIC Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 129

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Female or male patients, age 18 or older

* Willing to provide signed informed consent

* Life expectancy \> 6 months

* First presentation of AJCC Stage IV (any N, M1a, M1b, M1c), histologically confirmed cutaneous, acral or unknown primary melanoma with one to five extracranial metastases detected on CT and whole body PET-CT, and considered unresectable

* A primary lesion and / or up to 4 in-transit metastases(is) (ITM) in addition to distant metastases(is) are permitted and will be counted in the maximum number of permitted baseline lesions

* Prior surgery for symptomatic disease (e.g. small bowel obstruction) for this first presentation of Stage IV melanoma is permitted, provided the total number of remaining extracranial metastases is ≤ 5 (NOT including the resected lesion). No more than one excised metastatic lesion is permitted

* At least one metastasis should be measurable as a target lesion per RECIST version 1.1

* No evidence of cerebral metastases on MRI brain (CT brain is acceptable if there is contraindication to MRI)

* All lesions can be treated with a minimum SBRT biologically effective dose (BED) of 48Gy

* Able to tolerate treatment with immunotherapy as determined by the medical oncologist

* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2

* Women of childbearing potential (WOCBP) must have a negative serum pregnancy test within 7 days of randomisation

Exclusion Criteria:

* Ocular or mucosal melanoma

* Serious or unstable medical co-morbidities or other conditions that could interfere with the patient's safety, consent, or compliance

* Patients for whom there is a definite and immediate indication for radiotherapy (e.g., spinal cord compression, rapidly progressing disease associated with clinical signs and symptoms)

* Prior radiotherapy for Stage IV disease (prior adjuvant radiotherapy to primary site or nodal field (Stage I-III disease) is permitted, however adjuvant-treated sites must not be included in the baseline lesions

* Inability to treat all disease sites with SBRT as determined by radiation oncologist

* Prior systemic drug therapy for melanoma, unless given in the neoadjuvant or adjuvant setting for Stage I-III disease

* Any contraindication to the planned standard of care immunotherapy regimen per regulatory approved product information

* For patients with liver metastases - moderate/severe liver dysfunction

* A known history of another malignancy or concurrent malignancy unless the patient is disease-free for a minimum of 1 year, is completely treated and is at low risk of recurrence

* Pregnant or breastfeeding females

Dates on the record

Started 6 March 2025
Estimated completion 1 April 2033
Registry last updated 7 May 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 7 May 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.